In Bilski v. Kappos, the Court reiterated that abstract ideas are not patent eligible, gave little guidance as to what it meant by “abstract idea” other than that the Court was concerned about claims ...

In a unanimous decision, the U.S. Supreme Court ruled that a patent directed to adjusting a drug dosing regimen based on metabolite levels measured in the patient is not eligible for patent protection ...

With just one month to go before they present their arguments to the judges of the highest US court, the parties in Mayo v Prometheus have filed their briefs and interested parties are also making ...

Unfortunately this unspecific remand by the Supreme Court in AMP vacates as well the two-to-one ruling by this same Federal Circuit panel (Judges Lourie and Moore in the majority, Judge Bryson in ...

Mayo Collaborative Services v. Prometheus Laboratories Inc., No. 10-1150; U.S. Supreme Court; opinion by Breyer, J.; decided March 20, 2012. On certiorari to the U.S ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

The Supreme Court has agreed for a second time to hear Mayo v Prometheus, a case that tests the application of the Bilski ruling to diagnostic methods But in December last year, the Federal Circuit ...

Patent subject matter eligibility has emerged as arguably the most controversial patent policy theme of the past two decades, one which has been most keenly felt in the world of in vitro diagnostics ...

B Respondent, Prometheus Laboratories, Inc. (Prometheus), is the sole and exclusive licensee of the ’623 and ’302 patents. It sells diagnostic tests that embody the processes the patents describe. For ...